High-intensity focused ultrasound (HIFU) has shown promise as a pain management strategy in patients with bone metastases for whom other treatments are ineffective, according to researchers at the Sheba Medical Center in Israel (Ann Oncol 2007;18:163-167).
High-intensity focused ultrasound (HIFU) has shown promise as a pain management strategy in patients with bone metastases for whom other treatments are ineffective, according to researchers at the Sheba Medical Center in Israel (Ann Oncol 2007;18:163-167).
The goal of treatment for bone metastases is to relieve pain and reduce the risk of fracture. Treatment may consist of surgery, radiation therapy, pain medications, and/or bisphosphonate drugs.
In the study, 10 patients reported prolonged improvement in pain and/or a reduced dose of pain medication following MR-guided ultrasound ablation of bone metastases. One other patient found the MR-guided HIFU procedure too uncomfortable to complete treatment.
MR-guided HIFU is approved in the U.S. only for uterine fibroids, but researchers are investigating applications in breast, prostate, and brain tumors.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.